Pricing Log in Create free account

Obsidian Therapeutics, Inc (OBX) vs Syndax Pharmaceuticals, Inc. (SNDX)

Obsidian Therapeutics, Inc and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Obsidian Therapeutics, Inc and Syndax Pharmaceuticals, Inc. are of similar size ($863.4M and $795.6M). Across the 6 metrics below, Syndax Pharmaceuticals, Inc. leads on 4 and Obsidian Therapeutics, Inc on 2.

Valuation

Metric OBX SNDX Biotechnology median
P/E — n/m 11.58
P/S n/m 2.98 9.61
P/B n/m n/m 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales n/m 3.58 9.43
Earnings yield — (24.59%) (32.28%)
Free cash flow yield 0.00% (20.60%) (22.27%)

Profitability

Metric OBX SNDX Biotechnology median
Gross margin — 92.21% 68.81%
Operating margin — (61.72%) 0.00%
Net margin — (72.38%) 0.00%
Free cash flow margin — (61.36%) 0.00%
Return on equity — (426.43%) (50.30%)
Return on assets — (33.67%) (45.47%)
Return on invested capital 0.00% (83.42%) 0.00%

Growth

Metric OBX SNDX Biotechnology median
Revenue growth (TTM) — 159.46% 6.78%
EPS growth (last fiscal year) (11.60%) 11.56% 29.88%
Revenue growth, 5-year CAGR — 157.68% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric OBX SNDX Biotechnology median
Debt to equity 0.00 (34.24) 0.00
Current ratio 4.21 4.69 4.74
Net debt to EBITDA 0.77 0.25 1.01

Dividend

Metric OBX SNDX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric OBX SNDX Biotechnology median
Market cap 795.63m 863.37m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack